Skip to main content
. 2025 Feb 18;21(5):2027–2047. doi: 10.7150/ijbs.103723

Table 2.

Correlation between CD163 expression and clinicopathological parameters (n=48).

Characteristics n (%) CD163 expression
low high P
Age (years) 0.039
< 50 14 (29.1) 4 10
≥ 50 34 (70.9) 11 23
TNM stage 0.002
15 (31.2) 9 6
20 (41.7) 8 12
Ⅲ-Ⅳ 13 (27.1) 1 12
Ki-67 (%) 0.473
< 14 1 (2.1) 1 0
≥ 14 47 (97.9) 17 30